Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Neuron Biopharma SA - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Neuron Biopharma SA - Product Pipeline Review - 2014', provides an overview of the Neuron Biopharma SA's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Neuron Biopharma SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Neuron Biopharma SA including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Neuron Biopharma SA's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Neuron Biopharma SA's pipeline products Reasons to buy - Evaluate Neuron Biopharma SA's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Neuron Biopharma SA in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Neuron Biopharma SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Neuron Biopharma SA and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Neuron Biopharma SA - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Neuron Biopharma SA and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Neuron Biopharma SA Snapshot 5 Neuron Biopharma SA Overview 5 Key Information 5 Key Facts 5 Neuron Biopharma SA - Research and Development Overview 6 Key Therapeutic Areas 6 Neuron Biopharma SA - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Neuron Biopharma SA - Pipeline Products Glance 10 Neuron Biopharma SA - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Neuron Biopharma SA - Drug Profiles 11 NPS-0155 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 NSP-0163 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 NST-0003 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 NST-0004 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 NST-0005 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 NST-0037 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 NST-0060 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 NST-0076 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 NST-0078 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Neuron Biopharma SA - Pipeline Analysis 20 Neuron Biopharma SA - Pipeline Products by Target 20 Neuron Biopharma SA - Pipeline Products by Route of Administration 21 Neuron Biopharma SA - Pipeline Products by Molecule Type 22 Neuron Biopharma SA - Pipeline Products by Mechanism of Action 23 Neuron Biopharma SA - Recent Pipeline Updates 24 Neuron Biopharma SA - Dormant Projects 25 Neuron Biopharma SA - Locations And Subsidiaries 26 Head Office 26 Appendix 27 Methodology 27 Coverage 27 Secondary Research 27 Primary Research 27 Expert Panel Validation 27 Contact Us 28 Disclaimer 28
List of Tables Neuron Biopharma SA, Key Information 5 Neuron Biopharma SA, Key Facts 5 Neuron Biopharma SA - Pipeline by Indication, 2014 7 Neuron Biopharma SA - Pipeline by Stage of Development, 2014 8 Neuron Biopharma SA - Monotherapy Products in Pipeline, 2014 9 Neuron Biopharma SA - Preclinical, 2014 10 Neuron Biopharma SA - Pipeline by Target, 2014 20 Neuron Biopharma SA - Pipeline by Route of Administration, 2014 21 Neuron Biopharma SA - Pipeline by Molecule Type, 2014 22 Neuron Biopharma SA - Pipeline Products by Mechanism of Action, 2014 23 Neuron Biopharma SA - Recent Pipeline Updates, 2014 24 Neuron Biopharma SA - Dormant Developmental Projects,2014 25
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.